Tumor suppressor functions of ARLTS1 in lung cancers.
暂无分享,去创建一个
George A Calin | Massimo Negrini | Masayoshi Shimizu | Tamotsu Kuroki | Noel N Williams | Kristoffel R Dumon | Francesco Trapasso | Sai Yendamuri | C. Croce | M. Ferracin | Chang-gong Liu | G. Calin | M. Negrini | M. Shimizu | C. Sevignani | F. Bullrich | S. Yendamuri | T. Kuroki | K. Dumon | L. Kaiser | F. Trapasso | N. Williams | Carlo M Croce | Manuela Ferracin | Larry R Kaiser | Cinzia Sevignani | Chang-gong Liu | S. Rattan | R. Cesari | Rossano Cesari | Shashi Rattan | Florencia Bullrich
[1] B. Burwinkel,et al. Familial cancer and ARLTS1. , 2005, The New England journal of medicine.
[2] M. Su,et al. A novel human protease similar to the interleukin‐1 beta converting enzyme induces apoptosis in transfected cells. , 1995, The EMBO journal.
[3] A. Aventín,et al. Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies. , 1998, Blood.
[4] P-C Chang,et al. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control , 2006, Oncogene.
[5] L. Chin,et al. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. , 2006, Cancer cell.
[6] J. Moss,et al. Molecules in the ARF Orbit* , 1998, The Journal of Biological Chemistry.
[7] References , 1971 .
[8] M. Spitz,et al. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q , 1999, Oncogene.
[9] C. Der,et al. The ras superfamily of GTP‐binding proteins: guidelines on nomenclature , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] P. Bugert,et al. Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk , 2006, International journal of cancer.
[11] A. Godzik,et al. CARD6 Is a Modulator of NF-κB Activation by Nod1- and Cardiak-mediated Pathways* , 2003, Journal of Biological Chemistry.
[12] R. Houlston,et al. Familial cancer associated with a polymorphism in ARLTS1. , 2006, The New England journal of medicine.
[13] G. Pasinetti,et al. A role of P301L tau mutant in anti-apoptotic gene expression, cell cycle and apoptosis , 2003, Molecular and Cellular Neuroscience.
[14] K. Hemminki,et al. ARLTS1 variants and melanoma risk , 2006, International journal of cancer.
[15] H. Brenner,et al. ARLTS1 variants and risk of colorectal cancer. , 2006, Cancer letters.
[16] C. Putterman,et al. The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity. , 2004, Frontiers in bioscience : a journal and virtual library.
[17] Yan-Hwa Wu Lee,et al. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor. , 2006, Cancer research.
[18] R. Houlston,et al. Relationship between ARLTS1 polymorphisms and risk of chronic lymphocytic leukemia. , 2006, Leukemia research.
[19] R. Kahn,et al. Arf family GTPases: roles in membrane traffic and microtubule dynamics. , 2005, Biochemical Society transactions.
[20] D. Iliopoulos,et al. Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer. , 2006, Cancer research.
[21] M. Spitz,et al. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3 , 1999, Oncogene.
[22] M. Serrano,et al. Identification of a candidate tumor-suppressor gene specifically activated during Ras-induced senescence. , 2002, Experimental cell research.
[23] R. Scott,et al. Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene , 2006, Breast Cancer Research and Treatment.
[24] Y. Hsu,et al. Mouse and human neuronal pentraxin 1 (NPTX1): conservation, genomic structure, and chromosomal localization. , 1996, Genomics.
[25] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.